Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics

N. Passariello; F. Fici; D. Giugliano; A. Ceriello; P. Dello Russo; S. Sgambato

Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics

N. Passariello, F. Fici, D. Giugliano, A. Ceriello, P. Dello Russo, S. Sgambato

IRCCS Multimedica

Research output: Contribution to journal › Article › peer-review

Abstract

The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA₁, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.

Original language	English
Pages (from-to)	252-256
Number of pages	5
Journal	International Journal of Clinical Pharmacology Therapy and Toxicology
Volume	21
Issue number	5
Publication status	Published - 1983

ASJC Scopus subject areas

Toxicology
Pharmacology (medical)

Cite this

@article{d39a418f8c3c4a4bb07ba739c3c51203,

title = "Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics",

abstract = "The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA1, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.",

author = "N. Passariello and F. Fici and D. Giugliano and A. Ceriello and {Dello Russo}, P. and S. Sgambato",

year = "1983",

language = "English",

volume = "21",

pages = "252--256",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0174-4879",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "5",

}

TY - JOUR

T1 - Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics

AU - Passariello, N.

AU - Fici, F.

AU - Giugliano, D.

AU - Ceriello, A.

AU - Dello Russo, P.

AU - Sgambato, S.

PY - 1983

Y1 - 1983

N2 - The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA1, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.

AB - The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA1, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.

UR - http://www.scopus.com/inward/record.url?scp=0020541273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020541273&partnerID=8YFLogxK

M3 - Article

C2 - 6862730

AN - SCOPUS:0020541273

VL - 21

SP - 252

EP - 256

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

SN - 0174-4879

IS - 5

ER -

Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this